Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glargine versus regular insulin for perioperative glucose control in type 2 diabetes during vitrectomy
IRCT20141127020112N8Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Sep 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in type 2 diabetes mellitus (T2DM) comparing Glargine insulin with Regular insulin (2 arms). Primary endpoint: Blood glucose. Started Sep 2017; status: completed.
02
Drugs
insulin glarginehuman insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT20141127020112N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141127020112N8.